Adaptive Biotechnologies Corporation · NASDAQ:ADPT

Bobulsky Susan sold 5,000 Adaptive Biotechnologies Corporation shares (Form 4)

Traded Jul 16, 2026 · Filed Jul 20, 2026

On Jul 16, 2026, Bobulsky Susan (Chief Commercial Officer, MRD) sold 5,000 Adaptive Biotechnologies Corporation shares at US$23.00 for US$115K under a trading plan, leaving 401,288 shares. Filed Jul 20, 2026 (Form 4).

Sold
5,000 shares
Price
US$23.00
Value
US$115K
Holding after
401,288 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Commercial Officer, MRD

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 16, 2026Common StockSale5,000US$23.00401,288Direct

Source

View original at SEC

Related